FDA.reportPublic FDA data

12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Oscimin]

RxCUI
1149364
RxNorm name
12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Oscimin]
Display name
OSCIMIN XR (Oral Pill)
Full name
12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Oscimin]
Term type
SBD
Status
Active
Strength
0.375 mg
Dose form
12 HR XR Tab
Route
Oral Pill
Updated
2026-08-03 17:31:38

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
102011
Active start
102011
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
hyoscyamine sulfate0.375 MG / 1 EACHhyoscyaminehyoscyamine sulfate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Extended Release Oral Tablet316945

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
hyoscyamine153970

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STROscimin 0.375 MG 12 HR Extended Release Oral Tablet1NAMES
RxNorm Name12 HR hyoscyamine sulfate 0.375 MG Extended Release Oral Tablet [Oscimin]1NAMES
RxNorm SynonymOscimin 0.375 MG 12 HR Extended Release Oral Tablet1NAMES
TTYSBD1ATTRIBUTES
RxCUI11493641CODES
MMSL_CODEBD52691CODES

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
68047025501rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 0 matching rows.

No records found.

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
5361160c-c979-4a4f-8a46-fcf85560c967OSCIMIN SR TabletsLarken Laboratories, Inc.20211018
69165d39-1d76-4706-9e35-3cd37a4d2fd9National Council for Prescription Drug Programs20120724

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCA03BABelladonna alkaloids, tertiary aminesATC1-4hyoscyamine
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine sulfate
MEDRTD064692HyoscyamineCHEMhas_ingredienthyoscyamine
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine sulfate
MEDRTD000014Abnormalities, Drug-InducedDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine
MEDRTD003085ColicDISEASEmay_treathyoscyamine sulfate
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine
MEDRTD003093Colitis, UlcerativeDISEASEci_withhyoscyamine sulfate
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine
MEDRTD004342Drug HypersensitivityDISEASEci_withhyoscyamine sulfate
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine
MEDRTD018589GastroparesisDISEASEinduceshyoscyamine sulfate
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine sulfate
MEDRTD005901GlaucomaDISEASEci_withhyoscyamine
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine sulfate
MEDRTD006945HyperhidrosisDISEASEmay_treathyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine
MEDRTD007077Ileal DiseasesDISEASEci_withhyoscyamine sulfate
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine
MEDRTD007415Intestinal ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine
MEDRTD007431Intraoperative ComplicationsDISEASEmay_treathyoscyamine sulfate
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine sulfate
MEDRTD043183Irritable Bowel SyndromeDISEASEmay_treathyoscyamine
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine
MEDRTD008532Megacolon, ToxicDISEASEci_withhyoscyamine sulfate
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine
MEDRTD009127Muscle RigidityDISEASEmay_treathyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine sulfate
MEDRTD009157Myasthenia GravisDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine
MEDRTD017202Myocardial IschemiaDISEASEci_withhyoscyamine sulfate
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine
MEDRTD010437Peptic UlcerDISEASEmay_treathyoscyamine sulfate
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine
MEDRTD012220RhinitisDISEASEmay_treathyoscyamine sulfate
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine sulfate
MEDRTD012771Shock, HemorrhagicDISEASEci_withhyoscyamine
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine sulfate
MEDRTD012798SialorrheaDISEASEmay_treathyoscyamine
MEDRTD013035SpasmDISEASEmay_treathyoscyamine
MEDRTD013035SpasmDISEASEmay_treathyoscyamine sulfate
MEDRTD014202TremorDISEASEmay_treathyoscyamine
MEDRTD014202TremorDISEASEmay_treathyoscyamine sulfate
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine
MEDRTD014524Urethral ObstructionDISEASEci_withhyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine sulfate
MEDRTD001750Urinary Bladder, NeurogenicDISEASEmay_treathyoscyamine
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine
MEDRTD014987XerostomiaDISEASEinduceshyoscyamine sulfate
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000125Cholinergic Muscarinic AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000207Histamine Receptor AntagonistsMOAhas_moahyoscyamine
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine sulfate
MEDRTN0000000130Serotonin AntagonistsMOAhas_moahyoscyamine
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine sulfate
MEDRTN0000008331Cardiovascular Activity AlterationPEhas_pehyoscyamine
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine sulfate
MEDRTN0000008868Decreased Respiratory SecretionsPEhas_pehyoscyamine

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH0.375 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESQUANTITY12 HR
ATTRIBUTESRXNAV_HUMAN_DRUGUS
NAMESPrescribable SynonymOSCIMIN 0.375 MG 12HR Extended Release Oral Tablet
SOURCESSourceGold Standard Alchemy